dashboard
Signup Login



Biogen Stock Halted Pending FDA Decision On Alzheimer's Treatment

Biogen stock was halted Friday ahead of an FDA decision on the accelerated approval of its experimental Alzheimer's treatment, lecanemab.
Click Here To Get Funded!